Author

Yi-Fei Hu

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jan 2026

Mutation‐Immune Crosstalk Contextualizes CAF‐Associated ARPC1A Programs and Cisplatin Response in Gastric Cancer

Cisplatin response in gastric cancer is shaped by malignant cell programs, stromal states, and mutation‐immune crosstalk, but the CAF subtypes linked to platinum tolerance and their epithelial effectors remain incompletely defined. We integrated single‐cell RNA sequencing, epithelial CNV‐like inference, fibroblast recl...

Deyi Lu, Fanlai Meng, Weiying Zhou et al. · Human Mutation · 0 citations

Open access Aug 2026

Lymphangiogenesis-related gene signature–based risk model for prognostic assessment of cervical cancer: immune–metabolic characterization and molecular subtype analysis

Background Lymphangiogenesis promotes tumor dissemination and may shape the immune contexture of cervical cancer, yet lymphangiogenesis-related prognostic stratification and its immunometabolic implications remain insufficiently defined in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC). Methods...

Xi-Jing Fan, L. Chen, Jing Xu et al. · Frontiers in Genetics · 0 citations

Open access Aug 2026

Senescence-related immunosuppressive gene MFAP2 orchestrates stromal-immune crosstalk and immunotherapy resistance in gastric cancer

MFAP2 is a hub SRIG linking eCAFs, ECM remodeling, and immune escape in GC, which serves as a reliable prognostic and ICI resistance predictor and potential therapeutic target, providing a basis for precision therapy in GC.

Yi-Chan Hu, Liao-Xiang Zhu, Lijun Zhou et al. · BMC Cancer · 0 citations